Preferences between injectable contraceptive methods among South African women

Contraception

Volumn 73, Issue 6, 2006, Pages 598-601

  Morroni, Chelsea ^a   Myer, Landon ^a   Moss, Margaret ^b   Hoffman, Margaret ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Contraceptive preferences; DMPA; Injectable contraception; Norethisterone enanthate; South Africa

Indexed keywords

INJECTABLE CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE;

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; HUMAN EXPERIMENT; SOUTH AFRICA; URBAN AREA;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORETHINDRONE; PATIENT EDUCATION; PATIENT SATISFACTION; SOUTH AFRICA;

EID: 33646775708     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.01.005     Document Type: Article

References (12)

1. Baveja R., Buckshee K., Das K., et al. Evaluating contraceptive choice through the method-mix approach. An Indian Council of Medical Research (ICMR) Task Force study. Contraception 61 (2000) 113-119
2. Bongaarts J., and Johansson E. Future trends in contraceptive prevalence and method mix in the developing world. Stud Fam Plann 33 (2002) 24-36
3. South African Medical Research Council. 1998 South African Demographic and Health Survey: Final report. Tygerberg: South African Medical Research Council, South African Department of Health, and Macro International, 2001.
4. Cooper D., and Marks A.S. Community-based distribution of contraception: a pilot project in Khayelitsha, Cape Town. Urban Health News 30 (1996) 49-55
5. Burgard S. Factors associated with contraceptive use in late- and post-apartheid South Africa. Stud Fam Plann 35 (2004) 91-104
6. Margulies R., and Miller L. Increased depot medroxyprogesterone acetate use increases family planning program pharmaceutical supply costs. Contraception 63 (2001) 147-149
7. Smit J., Gray A., McFadyen L., and Zuma K. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. BMC Health Serv Res 1 (2001) 4
8. Constant D., Hoffman M., Cooper D., et al. The use of quantitative ultrasound to estimate bone mineral density in a study of contraceptive and other risk factors in South African women. Oral poster presentation, Reproductive Health Priorities Conference, Stellenbosch, South Africa, October (2005)
9. Directors of the Cape Metropolitan Regional Health Services, Purchasing and Finance Departments, Karl Bremer Hospital, Belville, South Africa. Personal communication, 2005.
10. Smit J., Gray A., and McFadyen L. Cost implications of injectable contraceptive utilisation patterns in South Africa. Abstracts of the Joint Meeting of VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR - Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). In: Velo G., and Perucca E. (Eds) (2000), Blackwell Science, Glasgow (UK) 93
11. World Health Organization. Medical eligibility for contraceptive use. 3rd ed. (2004), World Health Organization, Geneva
12. Chiou C.F., Trussell J., Reyes E., et al. Economic analysis of contraceptives for women. Contraception 68 (2003) 3-10